CTTI invites you to participate in a free, public webinar to learn about collaborative and innovative approaches to address the international public health crisis of antibacterial resistance. A panel of preeminent thought leaders will present these efforts, which appear in a recently published peer-reviewed supplement in the journal Clinical Infectious Diseases (CID).
The webinar will include the presentation of two new sets of CTTI recommendations designed to advance clinical trials for an important and particularly challenging area of antibacterial drug development: hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP).
This work is part of CTTI’s Antibacterial Drug Development (ABDD) Program, which includes a portfolio of projects tackling specific issues intended to improve clinical trials evaluating potential new antibacterial drugs.
We encourage you to share this invitation with others who may be interested in learning more about CTTI’s ABDD Program and the HABP/VABP Recommendations.
Webinar Title: Antibacterial Drug Development in a Time of Great Need: Global Expert Panel
Date & Time: Wednesday, August 24, 2016, from 12:00 p.m. – 1:00 p.m. EDT (New York, GMT-04:00)
Speakers:
- Edward Cox, MD, MPH, U.S. Food and Drug Administration
- Vance G. Fowler Jr, MD, MHS, Duke University
- Bruno François, MD, University Hospital of Limoges, France
- Hasan S. Jafri, MD, MedImmune
- John H. Powers III, MD, George Washington University School of Medicine
- John H. Rex, MD, AstraZeneca Pharmaceuticals
- Pamela Tenaerts, MD, MBA, Clinical Trials Transformation Initiative
Webinar Login: CLICK HERE to enter the meeting.
Meeting Number: 730 531 918
Meeting Password: ctti
After you connect to the website, please follow step-by-step instructions for connecting to the audio.
If you prefer to connect to audio only, you can join by phone at:
1-855-244-8681 Call-in toll-free number (US/Canada)
1-650-479-3207 Call-in toll number (US/Canada)